Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test. 2010

Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Kita-ku, Okayama 700-8558, Japan.

OBJECTIVE To examine the feasibility of predicting the flare-up of ulcerative colitis (UC) before symptoms emerge using the immunochemical fecal occult blood test (I-FOBT). METHODS We prospectively measured fecal hemoglobin concentrations in 78 UC patients using the I-FOBT every 1 or 2 mo. RESULTS During a 20 mo-period, 823 fecal samples from 78 patients were submitted. The median concentration of fecal hemoglobin was 41 ng/mL (range: 0-392 500 ng/mL). There were three types of patients with regard to the correlation between I-FOBT and patient symptoms; the synchronous transition type with symptoms (44 patients), the unrelated type with symptoms (19 patients), and the flare-up predictive type (15 patients). In patients with the flare-up predictive type, the values of I-FOBT were generally low during the study period with stable symptoms. Two to four weeks before the flare-up of symptoms, the I-FOBT values were high. Thus, in these patients, I-FOBT could predict the flare-up before symptoms emerged. CONCLUSIONS Flare-up could be predicted by I-FOBT in approximately 20% of UC patients. These results warrant periodical I-FOBT in UC patients.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009780 Occult Blood Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood. Fecal Occult Blood Test,Blood, Occult
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D005260 Female Females

Related Publications

Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
August 1999, Nihon rinsho. Japanese journal of clinical medicine,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
October 2007, Annals of internal medicine,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
February 2007, Annals of internal medicine,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
October 2016, Expert review of gastroenterology & hepatology,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
December 1984, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
February 2019, Journal of digestive diseases,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
April 2020, BMC gastroenterology,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
July 2022, Clinical and translational gastroenterology,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
September 2020, International journal of colorectal disease,
Motoaki Kuriyama, and Jun Kato, and Koji Takemoto, and Sakiko Hiraoka, and Hiroyuki Okada, and Kazuhide Yamamoto
December 2016, World journal of gastroenterology,
Copied contents to your clipboard!